Loading...
XNASCDMO
Market cap794mUSD
Jan 14, Last price  
12.42USD
1D
-0.08%
1Q
21.76%
Jan 2017
475.00%
Name

Avid Bioservices Inc

Chart & Performance

D1W1MN
XNAS:CDMO chart
P/E
—
P/S
5.68
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
2.46%
Rev. gr., 5y
21.15%
Revenues
140m
-6.27%
4,959,0003,193,0003,708,0006,093,00018,151,00027,943,00013,492,00015,233,00021,683,00022,401,00026,781,00044,686,00057,630,00053,621,00053,603,00059,702,00095,868,000119,597,000149,266,000139,911,000
Net income
-141m
L
-15,452,000-17,061,000-20,796,000-23,176,000-16,524,000-14,494,000-34,151,000-42,119,000-29,780,000-35,362,000-50,358,000-55,652,000-28,159,000-21,813,000-4,215,000-7,256,00011,212,000127,672,000560,000-140,753,000
CFO
11m
P
-13,168,000-16,957,000-18,479,000-20,927,000-10,030,000-13,865,000-26,462,000-35,878,000-20,926,000-28,254,000-36,019,000-39,591,000-39,786,000-26,766,000-11,595,0005,827,00031,182,0009,465,000-12,887,00010,952,000
Dividend
Mar 16, 20180.66 USD/sh
Earnings
Apr 22, 2025

Profile

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, purification, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. Avid Bioservices, Inc. has a process development and manufacturing agreement with Oragenics, Inc. to develop coronavirus vaccine. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was founded in 1981 and is headquartered in Tustin, California.
URL
https://avidbio.com/
IPO date
Oct 27, 1993
Employees
365
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑042023‑042022‑042021‑042020‑042019‑042018‑042017‑042016‑042015‑04
Income
Revenues
139,911
-6.27%
149,266
24.81%
119,597
24.75%
Cost of revenue
158,589
145,665
104,175
Unusual Expense (Income)
NOPBT
(18,678)
3,601
15,422
NOPBT Margin
2.41%
12.89%
Operating Taxes
113,826
1,443
(115,011)
Tax Rate
40.07%
NOPAT
(132,504)
2,158
130,433
Net income
(140,753)
-25,234.46%
560
-99.56%
127,672
1,038.71%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,396
3,406
3,359
BB yield
-0.29%
-0.30%
-0.35%
Debt
Debt current
2,804
141,981
2,969
Long-term debt
257,821
236,485
222,504
Deferred revenue
114,719
127,598
Other long-term liabilities
(140,623)
(139,577)
Net debt
222,519
339,574
98,957
Cash flow
Cash from operating activities
10,952
(12,887)
9,465
CAPEX
(31,805)
(77,638)
(56,411)
Cash from investing activities
(31,805)
(77,638)
(56,411)
Cash from financing activities
20,067
2,901
3,197
FCF
(139,290)
(88,966)
56,818
Balance
Cash
38,106
38,542
126,166
Long term investments
350
350
Excess cash
31,110
31,429
120,536
Stockholders' equity
(571,807)
(430,754)
(431,315)
Invested Capital
839,080
782,739
776,387
ROIC
0.28%
17.03%
ROCE
0.95%
4.32%
EV
Common stock shares outstanding
63,199
63,782
70,474
Price
7.63
-57.73%
18.05
34.10%
13.46
-37.13%
Market cap
482,208
-58.11%
1,151,265
21.37%
948,580
-25.44%
EV
704,727
1,490,839
1,047,537
EBITDA
(7,569)
10,811
19,902
EV/EBITDA
137.90
52.63
Interest
4,337
2,600
2,680
Interest/NOPBT
72.20%
17.38%